天津鹏翎集团股份有限公司投资者关系活动记录表 编号：2025-12-03 2 | | 不是急功近利的短时间到位。 | | | | --- | --- | --- | --- | | 附件清单（如有） | | | | | 日期 | 2025 年 3 日 | 12 | 月 | 证券代码：300375 证券简称：鹏翎股份 3 | 投资者关系活动类别 | 特定对象调研 分析师会议 | | --- | --- | | | 媒体采访 业绩说明会 | | | 新闻发布会 路演活动 | | | 现场参观 | | | 其他 | | 参与单位名称及人员姓名 | 中信证券组织的线上投资者交流会议 | | 时间 | 2025 年 12 月 03 日 15:30-16:30 | | 地点 | 线上 | | 上市公司接待人员姓名 | 公司董事、副总裁、董事会秘书 张鸿志 | | 投资者关系活动 | 一、介绍公司基本情况：公司发展历程、主营业务、公 | | | 司产品、公司三年战略规划、传感器投资业务等。 | | 主要内容介绍 | 二、互动交流情况： | | | 1、请介绍公司未来发展的规划以及未来投资所青睐的 | | | 领域？ | ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

Core Viewpoint - The company, Pengling Co., Ltd. (300375.SZ), plans to invest a total of 30 million yuan through equity transfer and capital increase to acquire an 8.49105% stake in Wuhan Liyan, with a pre-investment valuation of 520 million yuan [1] Group 1: Investment Strategy - The investment aligns with the company's three-year strategic plan and market development assessment, focusing on deepening its core business and enhancing profit margins [1] - The target company operates in the sensor industry, producing inductive position sensors primarily used in steering and braking systems, which can extend into the smart machinery components sector [1] Group 2: Industry and Technology - The sensor industry is characterized by its technological attributes, and the products produced by the target company have potential applications in higher-tech manufacturing [1] - The investment is aimed at optimizing and upgrading the company's product structure while enhancing its core competitiveness through strategic partnerships with quality enterprises in the upstream and downstream of the industry chain [1]

Core Viewpoint - The company Pengling Co., Ltd. plans to invest 30 million yuan in Wuhan Liyan Control Technology Co., Ltd., acquiring an 8.49% stake through equity transfer and capital increase [1] Group 1: Company Investment - Pengling Co., Ltd. will collaborate with Ma'anshan Shangqi Intelligent Venture Capital Partnership to invest in Wuhan Liyan [1] - The investment amount is set at 30 million yuan [1] - The investment will result in the company holding a total of 8.49% equity in Wuhan Liyan [1] Group 2: Industry Overview - Wuhan Liyan operates in the sensor industry, specifically producing inductive position sensors [1] - The products are primarily used in steering systems and braking systems [1] - The underlying technology of the products has potential applications in the smart machinery components sector [1]

Core Viewpoint - The company, Pengling Co., Ltd. (300375.SZ), plans to invest a total of 30 million yuan through equity transfer and capital increase to acquire an 8.49105% stake in Wuhan Liyan, with a pre-investment valuation of 520 million yuan [1] Group 1: Investment Strategy - The investment aligns with the company's three-year strategic plan and market development assessment, focusing on deepening its core business and enhancing profit margins [1] - The target company operates in the sensor industry, producing inductive position sensors primarily used in steering and braking systems, which can extend into the smart machinery components sector [1] Group 2: Industry and Technology - The sensor industry is characterized by its technological attributes, which are essential for the company's goal of transitioning towards a higher-tech manufacturing sector [1] - The investment is aimed at optimizing and upgrading the company's product structure while enhancing its core competitiveness through strategic partnerships with quality enterprises in the upstream and downstream of the industry chain [1]

每经AI快讯，鹏翎股份12月2日晚间发布公告称，公司第九届第十四次董事会临时会议于2025年12月2 日在天津市滨海新区中塘工业区葛万公路1703号公司主楼5楼516会议室以现场及通讯相结合的方式召 开。会议审议了《关于公司对外投资的议案》等文件。 （记者 王晓波） 每经头条（nbdtoutiao）——股民发帖求主力拉涨停，次日竟成真！襄阳轴承涨停迷局背后：平台审核 漏洞与市场操纵疑云发酵 ...

证券代码：300375 证券简称：鹏翎股份 公告编号：2025-054 天津鹏翎集团股份有限公司 关于公司对外投资的公告 重要内容提示： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 1 目标公司 19.25262 万元的新增注册资本，对应投前估值为 5.2 亿元；公司通过前 述股权受让及增资方式最终合计持有武汉理岩 8.49105%股权。 董事会审议前，该议案已经战略委员会审议通过。 特别提示： 1、本次交易完成后，天津鹏翎集团股份有限公司（以下简称"公司"或"鹏 翎股份"）将直接持有武汉理岩控制技术有限公司（以下简称"武汉理岩"或"目标 公司"）8.49105%的股权。 2、根据《深圳证券交易所创业板股票上市规则》《公司章程》等相关规定，本 次购买资产事项不构成关联交易，亦不构成《公司重大资产重组管理办法》规定的 重大资产重组。本次购买资产事项在董事会审批权限范围内，无需提交股东会审议。 风险提示： 1、本投资协议的签署对公司当期经营业绩和财务状况不构成重大影响，对公 司长期发展的影响需视后续推进和实施情况而定。公司将根据项目的进展情况及时 履行相关的决 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、会议召开情况 天津鹏翎集团股份有限公司（以下简称"公司"或"鹏翎股份"）于2025 年11月26日以电子邮件和电话的方式发出关于召开公司第九届董事会第十四次 （临时）会议的通知，会议于2025年12月2日上午10:30在天津市滨海新区中塘 工业区葛万公路1703号公司主楼5楼516会议室以现场及通讯相结合的方式召开。 证券代码：300375 证券简称：鹏翎股份 公告编号：2025-053 天津鹏翎集团股份有限公司 第九届董事会第十四次（临时）会议决议公告 1、审议通过《关于公司对外投资的议案》 经审议，董事会认为根据公司三年战略规划，公司本次对武汉理岩控制技术 有限公司的投资符合市场发展方向，有助于公司在深耕主业、强化利润率的基础 上，向更具前瞻性的业务领域进行业务拓展。董事会同意该议案。 2.第九届董事会战略委员会第七次会议决议； 公司本次会议应到董事8人，实到董事8人。本次会议由董事长王志方先生主 持，公司高级管理人员列席了会议。本次会议的召开符合《中华人民共和国公司 法》和《天津鹏翎集团股份有限公司章程 ...

Core Viewpoint - The company is investing a total of 30 million yuan in Wuhan Liyan Control Technology Co., Ltd. through equity transfer and capital increase, acquiring an 8.49105% stake at a pre-investment valuation of 520 million yuan [1] Investment Details - The investment is made in collaboration with Ma'anshan Shangqi Intelligent Venture Capital Partnership [1] - The funding sources for the investment will primarily come from the company's own funds [1] Industry Context - The target company operates in the sensor industry, characterized by technological attributes [1] - The products manufactured by the target company include inductive position sensors, which are mainly used in steering systems and braking systems [1] - The underlying technology and products have the potential to extend into the intelligent machinery components sector [1]

Core Viewpoint - Pengling Co., Ltd. reported that as of November 20, 2025, the total number of shareholders is 29,277 [2] Summary by Category - **Company Information** - The total number of shareholders for Pengling Co., Ltd. is 29,277 as of the specified date [2]